Search results
Results from the WOW.Com Content Network
A capping agent is used during nanoparticle synthesis to inhibit particle growth and aggregation. The chemical blocks or reduces reactivity at the periphery of the particle—a good capping agent has a high affinity for the new nuclei. [112] Citrate ions or tannic acid function both as a reducing agent and a capping agent.
Cellulose acetate phthalate (CAP), also known as cellacefate and cellulosi acetas phthalas, is a commonly used polymer phthalate in the formulation of pharmaceuticals, such as the enteric coating of tablets or capsules and for controlled release formulations.
An Ag + species and a capping agent are added (although the polyol itself is also often the capping agent). The Ag + species is then reduced by the polyol to colloidal nanoparticles. [ 25 ] The polyol process is highly sensitive to reaction conditions such as temperature, chemical environment, and concentration of substrates.
Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Unsourced material may be challenged and removed. Find sources: "List of antiviral drugs" – news · newspapers · books · scholar · JSTOR ( August 2020 ) ( Learn how and when to remove this message )
[4] [13] [14] The human capping enzyme is an example of a bifunctional polypeptide, which has both triphosphatase (N-terminal) and guanylyltransferase (C-terminal) domains. [ 15 ] [ 16 ] The human mRNA guanylyltransferase domain of the capping enzyme is composed of seven helices and fifteen β strands that are grouped into three, five and seven ...
In many cells these pits and complexes begin to concentrate in one area of a cell. Cytochemically, this appears as patches of label on the cell surface (patching). Eventually, the patches coalesce to form a cap at one pole of the cell (capping). Not all cells form caps, but most do form patches.
2,3-Dimercapto-1-propanesulfonic acid (abbreviated DMPS) and its sodium salt (known as Unithiol) are chelating agents that form complexes with various heavy metals. They are related to dimercaprol, which is another chelating agent. The synthesis of DMPS was first reported in 1956 by V. E. Petrunkin. [2]
Several classes of compounds have been researched as potential penetration enhancers through ocular membranes. These include chelating agents, cyclodextrins, surfactants, bile acids and salts, and crown ethers. [5] There are also reports on the use of cell penetrating peptides and chitosan as penetration enhancers in ocular drug delivery. [6]